- Home
- IPHA vs ISTR Comparison
IPHA vs ISTR Comparison
Compare IPHA & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- ISTR
- Stock Information
- Founded
- IPHA 1999
- ISTR 2006
- Country
- IPHA France
- ISTR United States
- Employees
- IPHA N/A
- ISTR N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- ISTR Major Banks
- Sector
- IPHA Health Care
- ISTR Finance
- Exchange
- IPHA Nasdaq
- ISTR Nasdaq
- Market Cap
- IPHA 160.1M
- ISTR 189.6M
- IPO Year
- IPHA 2019
- ISTR 2014
- Fundamental
- Price
- IPHA N/A
- ISTR $22.43
- Analyst Decision
- IPHA Strong Buy
- ISTR Buy
- Analyst Count
- IPHA 1
- ISTR 1
- Target Price
- IPHA $11.00
- ISTR $27.00
- AVG Volume (30 Days)
- IPHA 11.7K
- ISTR 41.9K
- Earning Date
- IPHA 03-27-2025
- ISTR 07-21-2025
- Dividend Yield
- IPHA N/A
- ISTR 1.92%
- EPS Growth
- IPHA N/A
- ISTR 22.25
- EPS
- IPHA N/A
- ISTR 2.19
- Revenue
- IPHA $20,831,349.00
- ISTR $88,885,000.00
- Revenue This Year
- IPHA $209.83
- ISTR $2.04
- Revenue Next Year
- IPHA $83.15
- ISTR $9.79
- P/E Ratio
- IPHA N/A
- ISTR $10.24
- Revenue Growth
- IPHA N/A
- ISTR 6.35
- 52 Week Low
- IPHA $1.29
- ISTR $14.91
- 52 Week High
- IPHA $3.51
- ISTR $24.81
- Technical
- Relative Strength Index (RSI)
- IPHA 39.24
- ISTR 74.15
- Support Level
- IPHA $1.71
- ISTR $19.17
- Resistance Level
- IPHA $1.92
- ISTR $19.34
- Average True Range (ATR)
- IPHA 0.09
- ISTR 0.71
- MACD
- IPHA -0.00
- ISTR 0.36
- Stochastic Oscillator
- IPHA 37.93
- ISTR 100.00
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.